TY - JOUR
T1 - Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm
AU - Rivardo, Fabrizio
AU - Martinotti, Maria Giovanna
AU - Turner, Raymond Joseph
AU - Ceri, Howard
N1 - Funding Information:
Funding : FR was supported by an Alberta Heritage Foundation for Medical Research block grant through Universities Technology International to HC and RJT. MGM is supported by a grant from the Marcopolo S.p.A (Borgo San Dalmazzo, Cuneo, Italy). HC and RJT are supported by grants from the Natural Science Engineering Research Council of Canada and the Canadian Institutes of Health Research.
PY - 2011/4
Y1 - 2011/4
N2 - Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm.
AB - Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm.
KW - Biofilm
KW - Biosurfactant
KW - Eradication
KW - Lipopeptide
KW - Synergy
KW - Uropathogenic Escherichia coli
UR - http://www.scopus.com/inward/record.url?scp=79952818043&partnerID=8YFLogxK
U2 - 10.1016/j.ijantimicag.2010.12.011
DO - 10.1016/j.ijantimicag.2010.12.011
M3 - Article
SN - 0924-8579
VL - 37
SP - 324
EP - 331
JO - International Journal of Antimicrobial Agents
JF - International Journal of Antimicrobial Agents
IS - 4
ER -